Circulating miR-320b Contributes to CD4+ T-Cell Proliferation in Systemic Lupus Erythematosus via MAP3K1

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by the production of autoantibodies and tissue inflammation. Mesenchymal stem cells (MSCs) have emerged as a promising candidate therapy for SLE owing to the immunomodulatory and regenerative properties. Circulating miR...

Full description

Saved in:
Bibliographic Details
Main Authors: Zutong Li, Rou Wang, Dandan Wang, Shujie Zhang, Hua Song, Shuai Ding, Yantong Zhu, Xin Wen, Hui Li, Hongwei Chen, Shanshan Liu, Lingyun Sun
Format: Article
Language:English
Published: Wiley 2023-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2023/6696967
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849395815110410240
author Zutong Li
Rou Wang
Dandan Wang
Shujie Zhang
Hua Song
Shuai Ding
Yantong Zhu
Xin Wen
Hui Li
Hongwei Chen
Shanshan Liu
Lingyun Sun
author_facet Zutong Li
Rou Wang
Dandan Wang
Shujie Zhang
Hua Song
Shuai Ding
Yantong Zhu
Xin Wen
Hui Li
Hongwei Chen
Shanshan Liu
Lingyun Sun
author_sort Zutong Li
collection DOAJ
description Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by the production of autoantibodies and tissue inflammation. Mesenchymal stem cells (MSCs) have emerged as a promising candidate therapy for SLE owing to the immunomodulatory and regenerative properties. Circulating miRNAs are small, single-stranded noncoding RNAs in a variety of body fluids that regulate numerous immunologic and inflammatory pathways. Recent studies have revealed many differentially expressed circulating miRNAs in autoimmune diseases including SLE. However, the role of circulating miRNAs in SLE has not been extensively studied. Here, we performed small RNA sequencing analysis to compare the circulating miRNA profiles of SLE patients before and after MSC transplantation (MSCT), and identified a significant decrease of circulating miR-320b level during MSCT. Importantly, we found that the expression of circulating miR-320b and its target gene MAP3K1 was closely associated with SLE disease activity. The in vitro experiments showed that decreased MAP3K1 level in SLE peripheral blood mononuclear cells (PBMCs) was involved in CD4+ T-cell proliferation. In MRL/lpr mice, miR-320b overexpression aggravated symptoms of SLE, while miR-320b inhibition could promote disease remission. Besides, MSCs regulate miR-320b/MAP3K1 expression both in vitro and in vivo. Our results suggested that circulating miR-320b and MAP3K1 may be involved in CD4+ T-cell proliferation in SLE. This trial is registered with NCT01741857.
format Article
id doaj-art-b77a1bda204b4ea986e8cd1c8e3ee81e
institution Kabale University
issn 2314-7156
language English
publishDate 2023-01-01
publisher Wiley
record_format Article
series Journal of Immunology Research
spelling doaj-art-b77a1bda204b4ea986e8cd1c8e3ee81e2025-08-20T03:39:29ZengWileyJournal of Immunology Research2314-71562023-01-01202310.1155/2023/6696967Circulating miR-320b Contributes to CD4+ T-Cell Proliferation in Systemic Lupus Erythematosus via MAP3K1Zutong Li0Rou Wang1Dandan Wang2Shujie Zhang3Hua Song4Shuai Ding5Yantong Zhu6Xin Wen7Hui Li8Hongwei Chen9Shanshan Liu10Lingyun Sun11Department of Rheumatology and ImmunologyDepartment of Rheumatology and ImmunologyDepartment of Rheumatology and ImmunologyMOE Key Laboratory of Model Animals for Disease StudyDepartment of Rheumatology and ImmunologyDepartment of Rheumatology and ImmunologyDepartment of Rheumatology and ImmunologyDepartment of Rheumatology and ImmunologyDepartment of RheumatologyDepartment of Rheumatology and ImmunologyDepartment of Rheumatology and ImmunologyDepartment of Rheumatology and ImmunologySystemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by the production of autoantibodies and tissue inflammation. Mesenchymal stem cells (MSCs) have emerged as a promising candidate therapy for SLE owing to the immunomodulatory and regenerative properties. Circulating miRNAs are small, single-stranded noncoding RNAs in a variety of body fluids that regulate numerous immunologic and inflammatory pathways. Recent studies have revealed many differentially expressed circulating miRNAs in autoimmune diseases including SLE. However, the role of circulating miRNAs in SLE has not been extensively studied. Here, we performed small RNA sequencing analysis to compare the circulating miRNA profiles of SLE patients before and after MSC transplantation (MSCT), and identified a significant decrease of circulating miR-320b level during MSCT. Importantly, we found that the expression of circulating miR-320b and its target gene MAP3K1 was closely associated with SLE disease activity. The in vitro experiments showed that decreased MAP3K1 level in SLE peripheral blood mononuclear cells (PBMCs) was involved in CD4+ T-cell proliferation. In MRL/lpr mice, miR-320b overexpression aggravated symptoms of SLE, while miR-320b inhibition could promote disease remission. Besides, MSCs regulate miR-320b/MAP3K1 expression both in vitro and in vivo. Our results suggested that circulating miR-320b and MAP3K1 may be involved in CD4+ T-cell proliferation in SLE. This trial is registered with NCT01741857.http://dx.doi.org/10.1155/2023/6696967
spellingShingle Zutong Li
Rou Wang
Dandan Wang
Shujie Zhang
Hua Song
Shuai Ding
Yantong Zhu
Xin Wen
Hui Li
Hongwei Chen
Shanshan Liu
Lingyun Sun
Circulating miR-320b Contributes to CD4+ T-Cell Proliferation in Systemic Lupus Erythematosus via MAP3K1
Journal of Immunology Research
title Circulating miR-320b Contributes to CD4+ T-Cell Proliferation in Systemic Lupus Erythematosus via MAP3K1
title_full Circulating miR-320b Contributes to CD4+ T-Cell Proliferation in Systemic Lupus Erythematosus via MAP3K1
title_fullStr Circulating miR-320b Contributes to CD4+ T-Cell Proliferation in Systemic Lupus Erythematosus via MAP3K1
title_full_unstemmed Circulating miR-320b Contributes to CD4+ T-Cell Proliferation in Systemic Lupus Erythematosus via MAP3K1
title_short Circulating miR-320b Contributes to CD4+ T-Cell Proliferation in Systemic Lupus Erythematosus via MAP3K1
title_sort circulating mir 320b contributes to cd4 t cell proliferation in systemic lupus erythematosus via map3k1
url http://dx.doi.org/10.1155/2023/6696967
work_keys_str_mv AT zutongli circulatingmir320bcontributestocd4tcellproliferationinsystemiclupuserythematosusviamap3k1
AT rouwang circulatingmir320bcontributestocd4tcellproliferationinsystemiclupuserythematosusviamap3k1
AT dandanwang circulatingmir320bcontributestocd4tcellproliferationinsystemiclupuserythematosusviamap3k1
AT shujiezhang circulatingmir320bcontributestocd4tcellproliferationinsystemiclupuserythematosusviamap3k1
AT huasong circulatingmir320bcontributestocd4tcellproliferationinsystemiclupuserythematosusviamap3k1
AT shuaiding circulatingmir320bcontributestocd4tcellproliferationinsystemiclupuserythematosusviamap3k1
AT yantongzhu circulatingmir320bcontributestocd4tcellproliferationinsystemiclupuserythematosusviamap3k1
AT xinwen circulatingmir320bcontributestocd4tcellproliferationinsystemiclupuserythematosusviamap3k1
AT huili circulatingmir320bcontributestocd4tcellproliferationinsystemiclupuserythematosusviamap3k1
AT hongweichen circulatingmir320bcontributestocd4tcellproliferationinsystemiclupuserythematosusviamap3k1
AT shanshanliu circulatingmir320bcontributestocd4tcellproliferationinsystemiclupuserythematosusviamap3k1
AT lingyunsun circulatingmir320bcontributestocd4tcellproliferationinsystemiclupuserythematosusviamap3k1